GGrantIndex
← Leaderboards

Michael Craig Sanguinetti

University Of Utah

$9,473,118
Attributed
$10,508,449
Total exposure
5
Grants
3
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $904.9K · FY200515
$1M$750K$500K$250K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15

Funding mix

By agency

NIH$10,508,449 · 5

By mechanism

R01$9,824,908 · 3
P50$620,166 · 1
R03$63,375 · 1

Top collaborators

Others in their field

Top investigators on “Potassium Channel

Research focus

Potassium ChannelXenopus OocyteVoltage /Patch ClampLong Qt SyndromeVentricular FibrillationMolecularBinding SitesBinding (Molecular Function)BaseMutantMapsAction PotentialsCardiacXenopusHeart Electrical ActivityCardiac MyocytesVoltageMovementExtracellularSensorSite-Directed MutagenesisCellsDesignPharmaceutical Preparations

Grant awards (33)

Physiology and Biophysics of Cardiac Slo2.1 Channels$511,156
R01 · FY2015 · HL · contact PI
Molecular mechanisms of hERG1 channel activators$366,912
R01 · FY2015 · HL · contact PI
Physiology and Biophysics of Cardiac Slo2.1 Channels$501,737
R01 · FY2014 · HL · contact PI
Molecular mechanisms of hERG1 channel activators$365,050
R01 · FY2014 · HL · contact PI
Molecular mechanisms of hERG1 channel activators$354,620
R01 · FY2013 · HL · contact PI
Physiology and Biophysics of Cardiac Slo2.1 Channels$531,120
R01 · FY2012 · HL · contact PI
Molecular mechanisms of hERG1 channel activators$373,750
R01 · FY2012 · HL · contact PI
Physiology and Biophysics of Cardiac Slo2.1 Channels$526,650
R01 · FY2011 · HL · contact PI
Molecular mechanisms of hERG1 channel activators$373,750
R01 · FY2011 · HL · contact PI
Modulation of cardiac K+ channels by drugs$362,911
R01 · FY2010 · HL · contact PI
Modulation of cardiac K+ channels by drugs$362,911
R01 · FY2009 · HL · contact PI
Modulation of cardiac K+ channels by drugs$362,911
R01 · FY2008 · HL · contact PI
Molecular Mechanisms of Pacemaker Channel Function$318,945
R01 · FY2008 · HL · contact PI
Modulation of cardiac K+ channels by drugs$362,911
R01 · FY2007 · HL · contact PI
Molecular Mechanisms of Pacemaker Channel Function$318,945
R01 · FY2007 · HL · contact PI
Modulation of cardiac K+ channels by drugs$373,750
R01 · FY2006 · HL · contact PI
Molecular Mechanisms of Pacemaker Channel Function$328,471
R01 · FY2006 · HL · contact PI
Molecular Mechanisms of Pacemaker Channel Function$336,375
R01 · FY2005 · HL
Modulation of cardiac K+ channels by drugs$337,500
R01 · FY2004 · HL
Modulation of cardiac K+ channels by drugs$337,500
R01 · FY2003 · HL
MOLECULAR MECHANISMS OF PACEMAKER CHANNEL FUNCTION$300,000
R01 · FY2003 · HL
Modulation of cardiac K+ channels by drugs$337,500
R01 · FY2002 · HL
MOLECULAR MECHANISMS OF PACEMAKER CHANNEL FUNCTION$300,000
R01 · FY2002 · HL
MOLECULAR PHYSIOLOGY OF LONG QT SYNDROME &IDIOPATHIC VENTRICULAR FIBRILLATION$206,722
P50 · FY2002 · HL
BLOCK OF MYOCARDIAL ION CHANNELS BY ANTIMALARIAL DRUGS$17,525
R03 · FY2002 · TW
Modulation of cardiac K+ channels by drugs$337,500
R01 · FY2001 · HL
MOLECULAR MECHANISMS OF PACEMAKER CHANNEL FUNCTION$300,000
R01 · FY2001 · HL
MOLECULAR PHYSIOLOGY OF LONG QT SYNDROME &IDIOPATHIC VENTRICULAR FIBRILLATION$206,722
P50 · FY2001 · HL
BLOCK OF MYOCARDIAL ION CHANNELS BY ANTIMALARIAL DRUGS$17,525
R03 · FY2001 · TW
MOLECULAR MECHANISMS OF PACEMAKER CHANNEL FUNCTION$299,167
R01 · FY2000 · HL
MODULATION OF CLASS III ANTIARRHYTHMIC DRUG EFFECTS$242,866
R01 · FY2000 · HL
MOLECULAR PHYSIOLOGY OF LONG QT SYNDROME &IDIOPATHIC VENTRICULAR FIBRILLATION$206,722
P50 · FY2000 · HL
BLOCK OF MYOCARDIAL ION CHANNELS BY ANTIMALARIAL DRUGS$28,325
R03 · FY2000 · TW